Topic: Cardiac rehabilitation Purpose: Regular exercise is a cornerstone of cardiac rehabilitation. Patients after TAVI represent a new, multi-morbid subgroup within rehabilitation, but no randomized study has evaluated the safety and effectivity of exercise in this population. Methods: In a prospective pilot study, 30 patients after TAVI (median age 81(IQR 8) yrs, 44% female, 84(55) days post-intervention) were randomized 1:1 to eight weeks of supervised combined endurance and strength training (TG) or to usual care (UC). The primary endpoint was change in peak oxygen uptake (VO2peak) assessed by cardiopulmonary exercise testing; secondary endpoints included muscular strength assessed in five large muscle groups by 1repetition maximum testing, 6-min walk test, and quality of life (KCCQ and SF12 questionnaires). Safety was assessed by documenting training-related adverse events, prosthesis (echocardiography) and kidney function. Results: In TG, exercise resulted in a significant (p=0.002) increase in VO2peak of 4.0(5.6) ml/ min/kg as compared to a non-significant (p=0.638) decrease of -1.0(4.0) in UC (group difference p=0.012). Muscular strength increased significantly (pall<0.010) in all muscle groups in TG, but remained unchanged in UC. Significant increases were observed in 6-min walk distance and in the physical function domains of the questionnaires in TG only. Three nontraining-related dropouts occurred (TG:2, UC:1); prosthesis and kidney function were not negatively affected by the exercise intervention. Conclusions: In patients after TAVI, combined exercise training appears safe and highly effective with respect to improvements in exercise capacity, muscular strength and quality of life. (ClinicalTrials.gov NCT01935297)
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Negative contribution of insulin therapy in course of chronic heart failure in patients with 2nd type diabetes mellitus N Natalia Koziolova 1 , J Nikonova 1 , N Nevolina 1 1 Medical Academy, Perm, Russian Federation Topic: Diabetes Objectives: to evaluate the dynamics of clinical signs, and left ventricle (LV) functional status, and NT-proBNP, and glycohemoglobin (HbA1c) in ischemic chronic heart failure (CHF) patients with 2nd type diabetes mellitus after using insulin therapy in compare with sulfonylurea drug (gliclazide in modified release form) combined with metformin. Methods: and materials: 84 ischemic CHF patients with 2nd type diabetes mellitus with no attainment of target HbA1c level during oral antihyperglycemia therapy were examined. Average age was 64,8AE8,1 years. Diabetes mellitus duration was 8,2+1,9 years. Average HbA1c was 9,7+1,9%. Average LV EF was 54,7+6,1%. Patients were randomized into 2 groups depending on antihyperglycemia strategy. The 1st group included patients who were transferred from previous therapy to gliclazide in modified released form and metformin (average daily dose was 68,8+9,5 mg and 1,87+1,23 g). The 2nd group included patients who started to take insulin in individual doses. Duration of therapy was 6 months. Systolic and diastolic function of LV was evaluated using echo. Groups were equal in sex, age, risk factors, duration and severity of CHF and 2nd type diabetes mellitus. Results: there were no significant changes in patients' clinical status and FC of angina and CHF, body mass, and HbA1c during therapy.Diastolic function parameters did not change reliably in 6 months, but difference in the dynamics of them was significant between groups. Parameter E decreased on 1,15 (-14,55;0,18 )% in 1st group and increased on 11,24 (-0,82;29,64)% in 2nd group(p=0,001). Parameter e'decreased on 1,8(-3,07;0,18;)% in 1st group and increased on 9,66(0,30;16,91)% in 2nd group(p=0,035). E/e' in 1st group decreased on 1,78 (-4,20;0,31, in 2nd group increased on 6,78 (0,15;18,19 ) (p<0,001). In 1st group non significant increase of NT-proBNP was estimated, but it was reliably less, than in 2nd group: 12,38(5,10;29,18)% vs 28,43(8,45;39,71 )% (p=0,022). During treating with insulin it was appeared tendency of LVMMI increase in compare with therapy by gliclazide in modified release form (p=0,078). Number of non-symptomatic hypoglycemia was reliably higher in 2nd group than in 1st: 2,14 (0,28;4,66) vs 7,21(1,89;12,09), (p<0,001). Conclusion: using insulin in ischemic CHF patients to treat 2nd type diabetes mellitus as distinguished from gliclazide in modified release form was associated with unfavorable structural and functional LV transformation and with increase of myocardial stress due to more frequent non-symptomatic hypoglycemia.
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Does chronic anemia change the benefit of exercised-based Cardiac Rehabilitation Program?
A Andre Monteiro 1 , A Abreu 1 , R Soares 1 , I Rodrigues 1 , P Rio 1 , SA Rosa 1 , A Gaspar 1 , D Mesquita 1 , S Silva 1 , RC Ferreira 1 1 Hospital Santa Marta, Department of Cardiology, Lisbon, Portugal Topic: Cardiac rehabilitation Background: Anemia is associated with adverse prognosis in patients with coronary heart disease but it is not well known whether it could influence cardiovascular performance indexes and prognosis immediately after an acute coronary syndrome (ACS). This study sought to assess its prevalence and to investigate the safety and efficacy of an intensive exercisebased cardiac rehabilitation (CR) in patients with anemia who suffered an ACS. Methods: We compared baseline characteristics of 209 consecutive ACS patients with (Group A) and without (Group B) chronic anemia, as defined according to World Health Organization criteria, who completed a CR program (60 minutes, twice a week sessions) between Jan/2004 and Dec/2013 in a tertiary center. CR outcomes were evaluated by cardiopulmonary exercise testing (CPET) (pre and post CR) comparing the degree of change in peak oxygen uptake (pVO2), percentage of predicted pVO2 (%predicted pVO2), minute ventilation/CO2 production (VE/VCO2) slope. Also, the difference between pre and post pVO2 (a˜pVO2) and %predicted pVO2 (a˜%pVO2) were calculated. Results: Anemia was detected in 27 patients (12.9% of the entire population, 46.4% male). Before rehabilitation, patients with anemia had lower body mass index (27.8 vs 30.3, p=0.037), higher baseline heart rate (75.8AE13.9 vs 71.2AE9.1, p=0.058) and elevated pro-BNP values (1387.5 vs 642.2, p=0.004). After CR, in Group A, pVO2 increased from 21.6+5.6 to 23.2+5.5 ml/kg/min (p=0.016); percentage of predicted pVO2 increased from 79.5+19.7% to 85.9+20.48 (p=0.013) and VE/VCO2 slope decreased from 27.12+5.4 to 26.70+5.5 (p=0.810). Group B got an increase in pVO2 from 25.8+6.9 to 27.7+7.3 ml/kg/min (p=0.000); percentage of predicted pVO2 increased from 89.8+24.1% to 95.3+28.5 (p=0.013) and VE/VCO2 slope decreased from 26.4+5.8 to 25.4+5.0 (p=0.051). Despite overall similar benefit with CR, when comparing both anemic and non anemic patients improvement, no significant differences were found in peak VO2 (a˜pVO2 2.86+5.47vs1.84+5.68; p=0.445) and in the percentage of predicted pVO2 (a˜%pVO2 8.62+17.1vs6.03+25.5; p=0.654). Conclusions: Anemia was uncommon among CR participants. Despite worst baseline functional capacity (inferior pVO2 and %pVO2), CR was as effective in improving cardiac performance after a short period of intensive exercise-based cardiac rehabilitation in anemic patients as it was among patients with normal hemoglobin value.
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Benefits of inspiratory muscle training in patients with pulmonary arterial hypertension I D Ioannis Laoutaris 1 , A Dritsas 1 , P Kariofyllis 1 , A Manginas 2 1 Onassis Cardiac Surgery Center, Athens, Greece, 2 Onassis Cardiac Surgery Center, Mediterraneo Hospital, Athens, Greece Topic: Cardiac rehabilitation Purpose: Patients with pulmonary arterial hypertension are characterized by respiratory muscle weakness, exertional dyspnea and poor functional status. However, the effects of training the respiratory muscles in this population are unknown. Thus, we sought to investigate the potential benefits of selective inspiratory muscle training (IMT). Methods: Ten patients (females, n=6, males, n=4) with pulmonary hypertension classified according to World Health Organization (WHO) as Group 1 (idiopathic n=2, associated with scleroderma n=2, pulmonary venous obstruction disease n=1, ventricular septum defect n=1, portal hypertension n=1) and Group 4 (chronic thromboembolic n=3) of mean age 55AE14 yrs, body mass index 26.4AE4.7 kg/m2, WHO class severity 2.5AE0.84 and systolic pulmonary artery pressure 83.3AE26.14 mmHg, participated in the study. Medical regimen was kept constant during the study. Patients were randomized (cluster randomization) to an IMT group (IMTG, n=5) and a Control group (CG, n=5). The IMTG underwent supervised high intensity training of the inspiratory muscles at 60% of sustained maximal inspiratory pressure (SPImax) using a computer biofeedback trainer (TrainairoˆÛ ) for 30 min, 3 times a week for 10 weeks. The CG did not undergo training. At the entry and end of the program all patients were evaluated for inspiratory muscle strength (PImax) and inspiratory work capacity (SPImax) with an electronic pressure manometer and designed-purpose software. Exercise capacity was assessed using the 6 min walk test (6MWT) and dyspnea by the Borg Scale (0-10) at the end of the 6MWT. Lung volumes were assessed using standard spirometry. Results: IMT resulted in a significant improvement in PImax (94.4AE16.8 vs. 63.8AE16.9 cmH2O, p=0.004) SPImax (412.8AE38 vs.261.6AE63 cmH2O/s/1000, p=0.009) 6MWT distance (436AE95 vs.391AE94 m, p=0.008), as well as dyspnea (2AE1 vs. 4.2AE1.9, p=0.03). No significant changes were shown in the CG while lung volumes did not significantly change in any of the groups. Conclusions: IMT resulted in an improvement in inspiratory muscle indices which was associated with an improvement in both dyspnea and exercise capacity in patients with pulmonary arterial hypertension. Further studies in a larger cohort of patients are needed in order to verify and elucidate the pathophysiological mechanisms of the present findings.
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Evaluation of novel inspiratory muscle indices in patients with chronic heart failure I D Ioannis Laoutaris 1 , S Adamopoulos 1 , A Manginas 1 , MS Kallistratos 1 , DV Cokkinos 1 , A Dritsas 1 1 Onassis Cardiac Surgery Center, Athens, Greece Topic: Exercise testing Purpose: Inspiratory muscle strength (PImax) is routinely measured in chronic heart failure (CHF). We sought to evaluate whether inspiratory musle work capacity (sustainedPImax [SPImax]) and inspiratory muscle contraction time (ICT) may represent stronger determinants of patients' functional status. Methods: Sixty patients with CHF, age 58AE10.6 yrs, LVEF 26AE7.8% of NYHA I (n=16)/II (n=20)/III (n=17)/IV (n=7) and 30 healthy subjects matched for age and body mass index were studied. The PImax was measured at the mouth as the maximal pressure generated at the 1st sec of inspiration at residual volume (RV) while SPImax as the integral of the sustained maximal inspiratory pressure in time i.e the area under a pressure-time curve from RV to total lung capacity (TLC), using an electronic pressure manometer with computer software. ICT was calulated as the time of contraction during maximal inspiratory effort. Patients also underwent cardiopulmonary exercise testing for measurement of peak oxygen consumption (peakVO2), 6 minute walk test (6MWT), resting echocardiography and evaluation of quality of life (QoL) using the Minnesota Living with Heart Failure Questionnaire (MLwHFQ), the Left Ventricular Dysfunction-36 (LVD-36) and the Duke Specific Activity Questionnaire (SAQ). Results: Mean peakVO2 was 15.9AE3.7 ml/kg/min and 6MWT was 359AE80 m. In CHF patients, SPImax, ICT, PImax were at 54%, 61% and 77% of the values measured in normals (SPImax, 321AE147 vs. 598AE85 cmH2O/s/1000, p<0.001), (ICT 9.3AE2.6 vs. 15.3AE1 s, p<0.001) (PImax, 81.1AE24 vs. 105AE15.4 cmH2O, p=0.02) respectively. All SPImax, ICT and PImax correlated with functional and quality of life markers (Table 1) . Conclusions: In addition to PImax, SPImax and ICT are emerging as novel inspiratory muscle indices associated with low functional status in patients with CHF while SPImax was the most severely depressed. Thus, training the inspiratory muscles in CHF patients may be more beneficial targeting inspiratory muscle work capacity rather than strength only. Topic: Cardiac rehabilitation Purpose: Accurate information regarding health and coronary artery disease (CAD) is necessary for patients to make informed choices and to self-manage their cardiac illness effectively. Although clinical guidelines typically stipulate that interventions as part of cardiac rehabilitation (CR) should be tailored and 'menu-driven', little is known about what patients' informational priorities are during this process. The aim of the current study was to undertake a systematic investigation of the educational priorities reported by a cohort of patients attending CR. Additional analyses were then carried out to examine the impact of demographic variables on these stated needs. Methods: A cross-sectional study design was employed with a cohort of cardiac patients attending a comprehensive hospital-based CR programme. 121 patients [71.3% male; mean age 66.73 (SD=10.83)] completed a questionnaire investigating their educational needs during CR. In addition to demographic information, patients were requested to complete the Information Needs in Cardiac Rehabilitation (INCR) tool. All data were analysed using SPSS 18.0. Independent t-tests examined the relationship between informational needs and age and gender respectively. Results: Regarding the 10 subject areas of the scale, patients rated emergency/safety, diagnosis and treatment, and the heart as the areas with the greatest information needs; and risk factors, general/social concerns, and work/vocational/social as their lowest information priorities. There were no differences between older (>60 years) and younger (<60 years) patients regarding educational needs. Female patients were more likely to seek information regarding when they should call 999 or go to the emergency room (p=0.019). Male patients were more likely to prioritise the following educational needs: what foods they should avoid while taking cardiac medictions (p=0.035), information on how both to cope with stress (p=0.006) and to reduce stress in their daily lives (p=0.007), information regarding which cardiac risk factors are controllable (p< 0.0001) and what can be done to control such risk factors (p=0.058). Conclusions: To optimise the benefits patients derive from CR, programmes should attempt to incorporate cardiac patients' informational preferences into educational interventions. Where feasible, particular attention should be paid to gender differences in educational priorities.
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Exercise training as a rehabilitation method for early postoperative cognitive dysfunction in patients undergoing coronary artery bypass grafting Topic: Cardiac rehabilitation Purpose: To assess the effect of aerobic exercise training on neuropsychological status in patients undergoing on-pump coronary artery bypass grafting (CABG). Material and Methods: 92 male CAD patients, undergoing on-pump CABG, were examined and enrolled into 2 groups: Group 1 with supervised cycling training (n=39, the mean age 55.5 AE 5.33 years) and Group 2 without cycling training program (n=53, the mean age 57.2 AE 6.21 years). The supervised regimen began 14 days postoperatively and included 3 trainings per week. Both groups were comparable in clinical and demographic data as well as in neuropsychological and intraoperative parameters. Neuropsychological status was assessed using the automated software complex oˆ¨Status PFoˆ£ on days 5-7 before CABG and 1 month after it. The following parameters were assessed: complex visual-motor reaction time, functional mobility of nervous processes and brain performance (reaction time and missed target signals) attention (Burdon's attention test), memory (10 numbers memorizing test). The statistical analysis was conducted using Statistica 8.0. Results: There were no significant differences in cognitive status of patients in both groups on days 7-10 in the postoperative period. 1 month after CABG patients with supervised cycling training demonstrated faster complex visual-motor reaction time (500.7 AE 55.1 ms vs. 535.1 AE 64.1 ms, p=0.03), lower rate of missed target signals during the functional mobility of nervous processes test (10.1 AE 1.2 vs. 14.0 AE 1.3, p = 0.04), the great number of processed signs on minute 1 (102.1 AE 27.7 vs. 77.7 AE 33.5, p = 0.01) and minute 4 (118.1 AE 28.4 vs. 101.2 AE 25.5, p= 0.03) as well as higher attention coefficient (60.9 AE 20.9 vs. 48.4 AE 19.9, p = 0.03) while completing the Burdon's attention test, compared to the patients without cycling training. There were no significant differences in memory performance in both groups. Conclusion: Three-week aerobic exercise training in the postoperative period contributes to neuropsychological recovery in patients, who have undergone CABG. Thus, early exercise training program may be considered as one of the rehabilitation methods for postoperative cognitive dysfunction.
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Pharmacological therapies in secondary prevention: the problem of intolerances.
A Altinier 1 , P Patrizia Maras 1 , S Doimo 1 , A Della Mattia 1 , G Sinagra 1 1 University Hospital Riuniti, Cardiovascular Dept and Postgraduate School Cardiovascular Sciences, Trieste, Italy Topic: Cardiac rehabilitation Background: Evidences show that after a coronary event the appropriate use of cardioprotective drugs, in addiction to risk factors control, improves long-term patient prognosis. These drugs are Acetylsalicylic Acid (ASA), B-Blockers (BB), Statins, Angiotensin-Converting Enzyme inhibitors (ACEi), Angiotensin Receptor Blockers (ARBs). However, mostly in the first months after the acute event, patients (pts) can experience intolerance to these drugs, which causes inhaderence to recommended therapies. Methods: To examinate pharmacological intolerances incidence and drug changes in the first 6 months after hospital discharge of pts revascularized with PTCA or CABG after an ACS. We included in a Registry all pts discharged alive from our Cardiovascular Department (CD) after ACS or myocardial revascularization procedure and referred to a cardiac rehabilitation program (January 2009-December 2010). Results: We analyzed 839 pts: 269 (32%) were female (F), 570 (68%) male (M), mean age 68AE10 years. Pts older than 75 years were 27% of the whole population. At discharge from CD, 799 (95%) pts were taking ASA, 600 (72%) BB, 502 (60%) ACEi, 183 (18%) ARBs, 725 (86%) Statins, 17 (2%) Ezetimibe/Simvastatin (E/S), 18 (2%) Ivabradina and 2 (0,2%) Ranolazine. Intolerances appeared for BB in 46 pts (5,5%, 8% F vs 5% M), ACEi in 84 (10%, 14% F vs 9% M), Statins in 64 (7,6%, 9% F vs 8% M) and ASA in 26 (3,1%, 6% F vs 2% M). All the intolerances needed a tailored treatment. In older pts, 7,7% experienced intolerances to BB, 11% to ACEi, 7 % to Statins and 2,9% to ASA. At the end of 6 months, 545 pts (65%) were taking BB, 470 (56%) ACEi, 227 (27%) ARBs, 700 (83%) Statins, 747 (89%) ASA, 57 (7%) E/S, 56 (7%) Ivabradine, 20 (2,4%) Ranolazine, with a significance difference from discharge for ARBs, E/S, Ivabradine and Ranolazine (p< 0.001). Conclusion: In our Registry of all comers, real world pts, we observed intolerances to recommended drugs that required a tailored therapy. Our analysis shows for females and older pts a trend to develop more side effects. At 6 months from discharge, the significant increase of ARBs, E/S, Ivabradine and Ranolazine reflects the clinical effort to reach the goal of an adequate secondary prevention target, suggested by international guidelines.
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